Request to Join
has invited you to join this group
Dr. Charles L. Loprinzi was born and raised in Portland, Oregon, attended Oregon State University and earned his M.D. degree from Oregon Health and Science University. He completed an internal medicine internship and residency at the Maricopa County General Hospital in Phoenix, AZ and a medical oncology fellowship at the University of Wisconsin Clinical Cancer Center.
Dr. Loprinzi has conducted more than 100 clinical trials regarding the prevention and/or treatment of symptoms caused by cancer and/or cancer therapy. His work is supported both by philanthropy and competitive grant funding garnered from various federal, foundation and industry sources. As a result of his efforts, Dr. Loprinzi has been commonly been invited to present on his work nationally and internationally. He has published over 450 articles and book chapters in high-impact scientific journals, including over 100 publications in the Journal of Clinical Oncology. Additionally he served as the founding editor for the “Art of Oncology” section of the Journal of Clinical Oncology.
Charles L. Loprinzi, M.D. has been in the Division of Medical Oncology at Mayo Clinic in Rochester, MN, since 1985. He holds the academic rank of professor of oncology and is recognized as the Regis Professor of Breast Cancer Research. He serves as a co-director of the Mayo Clinic Cancer Center Prevention and Control Program, and, as the chair of the Symptom Intervention Committee for the Alliance Cancer Cooperative Group. His past Mayo Clinic appointments include being the chair of the Division of Medical Oncology and the vice chair of the Department of Oncology.
Throughout his training and career, Dr. Loprinzi has received numerous awards, including the Komen Foundation Brinker Award; the Komen Foundation Professor of Survivorship Award; the Association of Community Cancer Centers’ Clinical Research Award; the North American Menopausal Society Vasomotor Symptoms Research Award; the Charles G. Moertel Memorial Lectureship and a 2015 Giants of Cancer Care award.
Dr. Navari received the Ph.D. degree at the University of Virginia, and the M.D. degree at the Medical College of Virginia. He received training in internal medicine at the University of Alabama in Birmingham, and was a Fellow in Hematology and Oncology at the Fred Hutchinson Cancer Research Center, University of Washington School of Medicine. He is board certified in internal medicine and medical oncology. From 1983 to 1998, he served on the Clinical Faculty of the University of Alabama Birmingham and was a practicing medical oncologist in the Simon-Williamson Clinic. During this time, he was Chairman of the Department of Medicine and President of the Simon-Williamson Clinic, Director of the Bone Marrow Transplantation Program and Director of the Comprehensive Cancer Program at Baptist Medical Center. In 1997, he was elected a Fellow of the American College of Physicians. During 1998-99, he was a Fellow in Clinical Medical Ethics in the MacLean Center for Clinical Medical Ethics at the University of Chicago. He joined the faculty of the College of Science of the University of Notre Dame (UND) in 1999 as Director of the Walther Cancer Research Center. He was appointed Associate Dean, College of Science, in 2000. In July, 2005, he became Professor of Medicine, Assistant Dean and Director, Indiana University School of Medicine South Bend (IUSM SB), and Adjunct Professor of Biochemistry, University of Notre Dame. In 2011, he was appointed Clinical Director, Harper Cancer Research Institute, a partnership between IUSM SB and UND. He was promoted to Associate Dean in 2012. Along with the medical students at IUSM SB, he founded the IUSM SB Student Outreach Clinic in 2013 and was appointed the Clinic’s first Medical Director. In 2014, he joined the World Health Organization as Director, Cancer Care Program, Eastern Europe. In 2015, he became Director, Cancer Care Program, Central and South America. Dr. Navari's research interests include supportive care in clinical oncology, development of antiemetics, palliative care, and the doctor-patient relationship in clinical oncology. He has published over one hundred thirty peer reviewed articles, with the most recent dealing with supportive care issues in clinical oncology.